RVMC & CHAI：2026拉丁美洲及加勒比地区可持续疫苗区域化生产布局的市场塑造战略白皮书（英文版）（18页）.pdf

1、Market-shaping strategy for a sustainable vaccine manufacturing footprint in LAC|1 Market-shaping strategy for a sustainable vaccine manufacturing footprint in Latin America and the Caribbean May 2026 Market-shaping strategy for a sustainable vaccine manufacturing footprint in LAC|2 Key takeaways Th

2、e COVID-19 pandemic exposed critical vulnerabilities in Latin America and the Caribbeans(LAC)vaccine manufacturing ecosystem.With less than 10%of the global population,the region accounted for nearly 30%of global COVID-19 deaths.A heavy reliance on imports left the region exposed when other countrie

3、s imposed export restrictions.Since then,the region has built meaningful momentum:new manufacturing partnerships have been created,and the share of PAHO Revolving Fund procurement regionally has grown from less than 1%in 2020 to 23%by 2025.Sustaining and building on this momentum will require moving

4、 toward an expanded coordinated regional footprint capable of meeting both the regions routine immunization needs and its preparedness for future health emergencies.However,this analysis highlights two key structural risks to the regions vaccine manufacturing ambitions:o Technology transfer agreemen

5、ts between originators and regional manufacturers have historically been limited in geographic scope,which left regional manufacturers commercially confined to single-country supply and unable to reach the scale that regional markets could otherwise support.Several recent examples demonstrate improv

6、ements.o Given the strength of the PAHO Revolving Fund as a pooled procurement mechanism,demand visibility for manufacturers has become generally high,but remains restricted by large countries procuring outside the Revolving Fund and country forecasts not always translating into full procurement vol